IGF2BP1 and melanoma: Similar to human melanoma cell line MEL928, proliferation of mouse SM1 cells was severely impaired by exposure to mouse recombinant interferon beta (mrIfn-β), and almost abolished after mrIfn-β treatment in Igf2bp1 deficient cells (Figure 3A, left graph).